Physician profile
Anthony A Cuneo
NPI 1982959888
$6,377.05
in general payments reported to CMS, 2019-2025
19 companies · $925 in 2025
The $925 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,116 · 2020: $1,742 · 2021: $875 · 2022: $374 · 2023: $808 · 2024: $537 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,250 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,249.92 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,268.69 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $1,786.21 | 2020-2025 | Intracept |
| Vertos Medical, INC. | $192.84 | 2021-2024 | Mild Device Kit |
| Pacira Therapeutics, INC. | $131.92 | 2019-2021 | |
| Horizon Therapeutics Plc | $123.72 | 2020-2021 | |
| Spr Therapeutics, INC | $111.55 | 2023-2025 | Sprint Pns System |
| Electronic Waveform Lab, INC. | $110.31 | 2021-2023 | |
| Nevro Corp. | $97.74 | 2022-2024 | Senza |
| Ferring Pharmaceuticals INC. | $95.66 | 2019-2025 | Euflexxa |
| Relievant Medsystems, INC. | $82.76 | 2020-2023 | Intracept |
| Bioventus LLC | $80.45 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $65.33 | 2020-2025 | Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $65.19 | 2025 | |
| Medtronic, INC. | $40.95 | 2022-2025 | Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $39.53 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $25.40 | 2023 | |
| Mml US, INC. | $24.85 | 2025 | Reactiv8 |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Sanofi-Aventis U.S. LLC | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cuneo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.